CHICAGO — Eliminating the use of opioids in the postoperative management of oculofacial surgery produced better pain control and subsequent patient satisfaction than standard of care regimens that included opioids, a presenter said here.
“Opioid-sparing therapy outperformed standard of care,” Monica M. Ray, MD, of TOC Eye and Face in Austin, Texas, said at the ASOPRS Fall Scientific Symposium.
Ray presented a study in which 20 participants in the study group underwent cosmetic surgery and agreed to the multimodal pain regimen while 20 participants in the control group, matched